 | ARN | Name: | 1-IMINO-5-PENTANONE | Formula: | C5 H9 N O | SMILES: | O=CCCCC=[N@H] | InChi: | InChI=1S/C5H9NO/c6-4-2-1-3-5-7/h4-6H,1-3H2 | Definition date: | 1999-09-22 | Last modified: | 2024-09-27 | Identifier: | (5E)-5-iminopentanal |
|
 | ARO | Name: | C-GAMMA-HYDROXY ARGININE | Formula: | C6 H15 N4 O3 | SMILES: | O=C(O)C(N)CC(O)CNC(N)=[NH2+] | InChi: | InChI=1S/C6H14N4O3/c7-4(5(12)13)1-3(11)2-10-6(8)9/h3-4,11H,1-2,7H2,(H,12,13)(H4,8,9,10)/p+1/t3-,4+/m1/s1 | Definition date: | 2000-09-05 | Last modified: | 2024-09-27 | Identifier: | amino{[(2R,4S)-4-amino-2,5-dihydroxy-5-oxopentyl]amino}methaniminium |
|
 | AS2 | Name: | (2R)-2-AMINO-4-OXOBUTANOIC ACID | Formula: | C4 H7 N O3 | SMILES: | O=CCC(N)C(=O)O | InChi: | InChI=1S/C4H7NO3/c5-3(1-2-6)4(7)8/h2-3H,1,5H2,(H,7,8)/t3-/m1/s1 | Synonyms: | ASPARTATE SEMIALDEHYDE | Definition date: | 2003-07-10 | Last modified: | 2024-09-27 | Identifier: | (2R)-2-amino-4-oxobutanoic acid |
|
 | ASA | Name: | ASPARTIC ALDEHYDE | Formula: | C4 H7 N O3 | SMILES: | O=CC(N)CC(=O)O | InChi: | InChI=1S/C4H7NO3/c5-3(2-6)1-4(7)8/h2-3H,1,5H2,(H,7,8)/t3-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-amino-4-oxobutanoic acid |
|
 | ASB | Name: | ASPARTIC ACID-4-CARBOXYMETHYL ESTER | Formula: | C6 H9 N O6 | SMILES: | O=C(OCC(=O)O)CC(C(=O)O)N | InChi: | InChI=1S/C6H9NO6/c7-3(6(11)12)1-5(10)13-2-4(8)9/h3H,1-2,7H2,(H,8,9)(H,11,12)/t3-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-4-(carboxymethoxy)-4-oxobutanoic acid (non-preferred name) |
|
 | ASD | Name: | 4-ANDROSTENE-3-17-DIONE | Formula: | C19 H26 O2 | SMILES: | O=C3CCC4C2C(C1(C(=CC(=O)CC1)CC2)C)CCC34C | InChi: | InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1 | Definition date: | 2000-02-23 | Last modified: | 2024-09-27 | Identifier: | androst-4-ene-3,17-dione |
|
 | ASJ | Name: | (3S)-3-amino-4-hydroxybutanoic acid | Formula: | C4 H9 N O3 | SMILES: | O=C(O)CC(N)CO | InChi: | InChI=1S/C4H9NO3/c5-3(2-6)1-4(7)8/h3,6H,1-2,5H2,(H,7,8)/t3-/m0/s1 | Definition date: | 2010-10-07 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-amino-4-hydroxybutanoic acid |
|
 | ASL | Name: | ASPARTIC ACID-4-CARBOXYETHYL ESTER | Formula: | C7 H11 N O6 | SMILES: | O=C(OC(C(=O)O)C)CC(C(=O)O)N | InChi: | InChI=1S/C7H11NO6/c1-3(6(10)11)14-5(9)2-4(8)7(12)13/h3-4H,2,8H2,1H3,(H,10,11)(H,12,13) | Definition date: | 1999-09-09 | Last modified: | 2024-09-27 | Identifier: | 2-amino-4-(1-carboxyethoxy)-4-oxobutanoic acid (non-preferred name) |
|
 | ASN | Name: | ASPARAGINE | Formula: | C4 H8 N2 O3 | SMILES: | O=C(N)CC(N)C(=O)O | InChi: | InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)/t2-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | L-asparagine |
|
 | ASO | Name: | 1,5-anhydro-D-glucitol | Formula: | C6 H12 O5 | SMILES: | OC1C(OCC(O)C1O)CO | InChi: | InChI=1S/C6H12O5/c7-1-4-6(10)5(9)3(8)2-11-4/h3-10H,1-2H2/t3-,4+,5+,6+/m0/s1 | Synonyms: | 1,5-ANHYDROSORBITOL | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 1,5-anhydro-D-glucitol |
|
 | ASP | Name: | ASPARTIC ACID | Formula: | C4 H7 N O4 | SMILES: | O=C(O)CC(N)C(=O)O | InChi: | InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | L-aspartic acid |
|
 | ASY | Name: | (12E)-10-oxooctadec-12-enoic acid | Formula: | C18 H32 O3 | SMILES: | O=C(C/C=C/CCCCC)CCCCCCCCC(=O)O | InChi: | InChI=1S/C18H32O3/c1-2-3-4-5-8-11-14-17(19)15-12-9-6-7-10-13-16-18(20)21/h8,11H,2-7,9-10,12-16H2,1H3,(H,20,21)/b11-8+ | Definition date: | 2008-03-10 | Last modified: | 2024-09-27 | Identifier: | (12E)-10-oxooctadec-12-enoic acid |
|
 | ATJ | Name: | ETHYL HYDROGEN PHOSPHONATE | Formula: | C2 H7 O3 P | SMILES: | O=P(O)OCC | InChi: | InChI=1S/C2H7O3P/c1-2-5-6(3)4/h6H,2H2,1H3,(H,3,4) | Definition date: | 2005-09-07 | Last modified: | 2024-09-27 | Identifier: | ethyl hydrogen (R)-phosphonate |
|
 | AUX | Name: | 4-METHYL-4-[8-QUINOLINIUM-4-ENE]-4,N-METHYL-THREONINE | Formula: | C21 H29 N2 O3 | SMILES: | CN[CH]([CH](O)[CH](C)CC=CCCC[n+]1cccc2ccccc12)C(O)=O | InChi: | InChI=1S/C21H28N2O3/c1-16(20(24)19(22-2)21(25)26)10-5-3-4-8-14-23-15-9-12-17-11-6-7-13-18(17)23/h3,5-7,9,11-13,15-16,19-20,22,24H,4,8,10,14H2,1-2H3/p+1/b5-3+/t16-,19+,20-/m1/s1 | Definition date: | 2015-05-14 | Last modified: | 2024-09-27 | Release date: | 2015-12-29 | Identifier: | (E,2S,3R,4R)-4-methyl-2-(methylamino)-3-oxidanyl-10-quinolin-1-ium-1-yl-dec-6-enoic acid |
|
 | AVH | Name: | (1R,2R,4R)-4-ethenylcyclohexane-1,2-diol | Formula: | C8 H14 O2 | SMILES: | C1(CCC(C=C)CC1O)O | InChi: | InChI=1S/C8H14O2/c1-2-6-3-4-7(9)8(10)5-6/h2,6-10H,1,3-5H2/t6-,7?,8-/m1/s1 | Definition date: | 2016-11-11 | Last modified: | 2024-09-27 | Release date: | 2017-10-11 | Identifier: | (1R,2R,4R)-4-ethenylcyclohexane-1,2-diol |
|
 | AVN | Name: | (2S)-AMINO[(5S)-3-CHLORO-4,5-DIHYDROISOXAZOL-5-YL]ACETIC ACID | Formula: | C5 H7 Cl N2 O3 | SMILES: | ClC1=NOC(C(C(=O)O)N)C1 | InChi: | InChI=1S/C5H7ClN2O3/c6-3-1-2(11-8-3)4(7)5(9)10/h2,4H,1,7H2,(H,9,10)/t2-,4-/m0/s1 | Synonyms: | ACIVICIN | Definition date: | 2007-09-24 | Last modified: | 2024-09-27 | Identifier: | (2S)-amino[(5S)-3-chloro-4,5-dihydroisoxazol-5-yl]ethanoic acid |
|
 | AVU | Name: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl
[(2R,3R,4R)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate | Formula: | C15 H22 F N5 O12 P2 | SMILES: | FC1C(O)C(OC1)COP(=O)(O)OP(=O)(O)OCC4OC(n3cnc2c(ncnc23)N)C(O)C4O | InChi: | InChI=1S/C15H22FN5O12P2/c16-6-1-29-7(10(6)22)2-30-34(25,26)33-35(27,28)31-3-8-11(23)12(24)15(32-8)21-5-20-9-13(17)18-4-19-14(9)21/h4-8,10-12,15,22-24H,1-3H2,(H,25,26)(H,27,28)(H2,17,18,19)/t6-,7-,8-,10+,11-,12-,15-/m1/s1 | Synonyms: | arabinosyl-2-fluoro-deoxy-adenosine diphosphate ribose, ara-2'F-ADPR | Definition date: | 2009-07-14 | Last modified: | 2024-09-27 | Identifier: | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3R,4R)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name) |
|
 | AVY | Name: | (1R,2S)-2-{[N-({[4-benzyl-1-(tert-butoxycarbonyl)piperidin-4-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C31 H48 N4 O10 S | SMILES: | C(CC1CCNC1=O)(C(S(O)(=O)=O)O)NC(C(CC(C)C)NC(=O)OC3(Cc2ccccc2)CCN(CC3)C(=O)OC(C)(C)C)=O | InChi: | InChI=1S/C31H48N4O10S/c1-20(2)17-23(26(37)33-24(27(38)46(41,42)43)18-22-11-14-32-25(22)36)34-28(39)44-31(19-21-9-7-6-8-10-21)12-15-35(16-13-31)29(40)45-30(3,4)5/h6-10,20,22-24,27,38H,11-19H2,1-5H3,(H,32,36)(H,33,37)(H,34,39)(H,41,42,43)/t22-,23-,24-,27+/m0/s1 | Synonyms: | bound form | Definition date: | 2017-07-28 | Last modified: | 2024-09-27 | Release date: | 2018-04-04 | Identifier: | (1R,2S)-2-{[N-({[4-benzyl-1-(tert-butoxycarbonyl)piperidin-4-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | AW4 | Name: | (1S,2S)-2-[(N-{[2-(3-chlorophenyl)ethoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C22 H32 Cl N3 O8 S | SMILES: | C1(=O)NCCC1CC(NC(C(NC(=O)OCCc2cccc(c2)Cl)CC(C)C)=O)C(O)S(O)(=O)=O | InChi: | InChI=1S/C22H32ClN3O8S/c1-13(2)10-17(26-22(30)34-9-7-14-4-3-5-16(23)11-14)20(28)25-18(21(29)35(31,32)33)12-15-6-8-24-19(15)27/h3-5,11,13,15,17-18,21,29H,6-10,12H2,1-2H3,(H,24,27)(H,25,28)(H,26,30)(H,31,32,33)/t15-,17-,18-,21-/m0/s1 | Synonyms: | bound form | Definition date: | 2017-07-28 | Last modified: | 2024-09-27 | Release date: | 2018-04-04 | Identifier: | (1S,2S)-2-[(N-{[2-(3-chlorophenyl)ethoxy]carbonyl}-L-leucyl)amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | AWQ | Name: | 3-[4-(2-hydroxy-2-oxoethyl)-2,5-dimethyl-1~{H}-pyrrol-3-yl]propanoic acid | Formula: | C11 H15 N O4 | SMILES: | Cc1[nH]c(C)c(CC(O)=O)c1CCC(O)=O | InChi: | InChI=1S/C11H15NO4/c1-6-8(3-4-10(13)14)9(5-11(15)16)7(2)12-6/h12H,3-5H2,1-2H3,(H,13,14)(H,15,16) | Definition date: | 2017-08-29 | Last modified: | 2024-09-27 | Release date: | 2017-09-06 | Identifier: | 3-[4-(2-hydroxy-2-oxoethyl)-2,5-dimethyl-1~{H}-pyrrol-3-yl]propanoic acid |
|
 | AWX | Name: | N-({4-[4-amino-3-(3,5-dimethyl-1-benzofuran-2-yl)-7-oxo-6,7-dihydro-2H-pyrazolo[3,4-d]pyridazin-2-yl]phenyl}methyl)prop-2-enamide | Formula: | C25 H22 N6 O3 | SMILES: | C=[C@H]C(=O)NCc1ccc(cc1)n4c(c2oc3c(c2C)cc(C)cc3)c5c(n4)C(NN=C5N)=O | InChi: | InChI=1S/C25H22N6O3/c1-4-19(32)27-12-15-6-8-16(9-7-15)31-22(20-21(30-31)25(33)29-28-24(20)26)23-14(3)17-11-13(2)5-10-18(17)34-23/h4-11H,1,12H2,2-3H3,(H2,26,28)(H,27,32)(H,29,33) | Definition date: | 2018-12-04 | Last modified: | 2024-09-27 | Release date: | 2019-10-23 | Identifier: | N-({4-[4-amino-3-(3,5-dimethyl-1-benzofuran-2-yl)-7-oxo-6,7-dihydro-2H-pyrazolo[3,4-d]pyridazin-2-yl]phenyl}methyl)prop-2-enamide |
|
 | AX9 | Name: | DiCys-(15,16)-Dihydrobiliverdin | Formula: | C33 H40 N4 O6 | SMILES: | O=C(O)CCc1c(C)c(/C=C2NC(=O)C(C)=C2CC)[NH]c1/C=C1N=C(CC2NC(=O)C(CC)=C2C)C(C)=C1CCC(=O)O | InChi: | InChI=1S/C33H40N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h14-15,26,35H,7-13H2,1-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b27-14-,28-15-/t26-/m1/s1 | Synonyms: | 15,16-DIHYDROBILIVERDIN (double Cys bound form) | Definition date: | 2021-11-11 | Last modified: | 2024-09-27 | Release date: | 2023-02-15 | Identifier: | 3-[(2Z)-2-({3-(2-carboxyethyl)-5-[(Z)-(3-ethyl-4-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl}methylidene)-5-{[(2R)-4-ethyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-yl]methyl}-4-methyl-2H-pyrrol-3-yl]propanoic acid |
|
 | AXD | Name: | 2-[4-({2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-2-OXOETHYL}AMINO)-4-METHYLPIPERIDIN-1-YL]ISONICOTINIC ACID | Formula: | C21 H29 N5 O3 | SMILES: | O=C(O)c1cc(ncc1)N3CCC(NCC(=O)N2C(C#C)CCC2CN)(CC3)C | InChi: | InChI=1S/C21H29N5O3/c1-3-16-4-5-17(13-22)26(16)19(27)14-24-21(2)7-10-25(11-8-21)18-12-15(20(28)29)6-9-23-18/h1,6,9,12,16-17,24H,4-5,7-8,10-11,13-14,22H2,2H3,(H,28,29)/t16-,17-/m0/s1 | Definition date: | 2006-08-23 | Last modified: | 2024-09-27 | Identifier: | 2-[4-({2-[(2S,5R)-2-(aminomethyl)-5-ethynylpyrrolidin-1-yl]-2-oxoethyl}amino)-4-methylpiperidin-1-yl]pyridine-4-carboxylic acid |
|
 | AXL | Name: | 2-{1-[2-AMINO-2-(4-HYDROXY-PHENYL)-ACETYLAMINO]-2-OXO-ETHYL}-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID | Formula: | C16 H21 N3 O5 S | SMILES: | O=C(NC(C=O)C1SC(C(N1)C(=O)O)(C)C)C(c2ccc(O)cc2)N | InChi: | InChI=1S/C16H21N3O5S/c1-16(2)12(15(23)24)19-14(25-16)10(7-20)18-13(22)11(17)8-3-5-9(21)6-4-8/h3-7,10-12,14,19,21H,17H2,1-2H3,(H,18,22)(H,23,24)/t10-,11-,12+,14-/m1/s1 | Synonyms: | AMOXICILLIN, bound form | Definition date: | 2002-05-07 | Last modified: | 2024-09-27 | Identifier: | (2R,4S)-2-[(1R)-1-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
 | AY0 | Name: | (1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropanecarboxylic acid | Formula: | C12 H14 N O7 P | SMILES: | O=C(NC)C2C(c1ccc(OP(=O)(O)O)cc1)C2C(=O)O | InChi: | InChI=1S/C12H14NO7P/c1-13-11(14)9-8(10(9)12(15)16)6-2-4-7(5-3-6)20-21(17,18)19/h2-5,8-10H,1H3,(H,13,14)(H,15,16)(H2,17,18,19)/t8-,9+,10+/m0/s1 | Definition date: | 2010-10-09 | Last modified: | 2024-09-27 | Identifier: | (1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropanecarboxylic acid |
|